Skip to main content
. Author manuscript; available in PMC: 2009 Oct 1.
Published in final edited form as: Schizophr Res. 2008 Jul 11;105(1-3):188–196. doi: 10.1016/j.schres.2008.06.003

Figure 2. Prevalence of moderate to severe symptoms over time in chronic schizophrenia patients who had no measurable increases in psychosis (n=56) – raw data.

Figure 2

Baseline (week 0) is the last rating on haloperidol treatment.